drugset / Trial / NCT00513253
A Phase I Study to Test Alternate Oral Formulations vs the Current Tablet Formulation of Lapatinib
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed to estimate the relative bioavailability of alternative lapatinib oral formulations compared to the current tablet formulation.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-05
- Completion
- 2008-05
Outcome
Outcome not reported
Stopped: “It was determined not to be needed based on the clinical development plan of Tykerb.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapatinib | Small molecule | — | Oral |
Indications
No indication recorded.